Avascular Necrosis
132
6
33
48
Key Insights
Highlights
Success Rate
56% trial completion
Published Results
26 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
28.8%
38 terminated out of 132 trials
55.8%
-30.7% vs benchmark
18%
24 trials in Phase 3/4
54%
26 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (132)
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Database Retrieval for the Comprehensive Shoulder
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Shoulder Prosthesis System
TESS V3 Modular Total Shoulder System PMCF
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
Insignia™ Hip Stem Outcomes Study
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Cemented vs Cementless Persona Keel RCT
Persona Partial Knee Clinical Outcomes Study
Comprehensive Nano - Post Market Clinical Follow-Up Study
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
Anatomical Shoulder Domelock System Study
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Perform Humeral System Study
Pyrocarbon Clinical Follow-up Study
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert